Sharon L. Camp, President and CEO
Sharon L. Camp is President and CEO of the Guttmacher Institute, the leading policy research organization in the field of sexual and reproductive health. Prior to joining Guttmacher, Dr. Camp was President and CEO of Women’s Capital Corporation, a start-up company responsible for the development and commercialization of Plan B emergency contraception. For many years the leading spokesperson in Washington, DC for international family planning programs, she was also largely responsible for bringing together the highly successful International Consortium for Emergency Contraception and served until April 1998 as its Coordinator. From 1975 to 1993, Dr. Camp was Senior Vice President of Population Action International, managing PAI’s professional staff involved in lobbying, media liaison, policy research and publications. She is a widely quoted authority on the national and international politics of contraception, a popular public speaker, and the author or co-author of more than 70 publications on family planning and related subjects, including articles on emergency contraception. Dr. Camp has chaired the boards of Family Health International, the National Council for International Health and the International Center for Research on Women and was founding chair of the Reproductive Health Technologies Project, sponsor of the Emergency Contraceptive Hotline (1-888-NOT-2-LATE). She has served as an elected director of the National Family Planning and Reproductive Health Association (NFPRHA), AVSC International, Management Sciences for Health and Population Action International, and currently serves as a Senior Lecturer in the Department of Population and Family Health at Columbia University's Mailman School of Public Health. Dr. Camp is an honors graduate of Pomona College and holds an M.A. and a Ph.D. from Johns Hopkins University.
Recent Publications Include:
Dr. Camp is a frequent contributor to blogs and other online publications, where she comments on issues related to sexual and reproductive health in the United States and worldwide. Follow these links to read Dr. Camp’s recent contributions to the Huffington Post and RH Reality Check.
Camp SL, Wilkerson DS and Raine TR, The benefits and risks of over-the-counter availability of levonorgestrel emergency contraception, Contraception , 2003, 68:309-317.
Raymond EG, Dalebout SM and Camp SL, Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product, Obstetrics & Gynecology 2002; 100: 342-349.
Camp SL, The Status of Dedicated Products, Journal of the American Medical Women’s Association, 1998 Supplement on Emergency contraception 2: 255.
Ellerston C, Winnikoff B, Armstrong E, Camp S and Senayake P, Expanding Access to Emergency Contraception in Developing Countries, Studies in Family Planning, September/October 1995, 26(5).
Camp, SL, Emergency Contraception in Seven European Countries, September 1994, Reproductive Health Technologies Project.
Stegall, L and Camp SL, Emergency Reproductive Health Services to the Victims of Sexual Violence in the Former Yugoslavia, November 1993, Reproductive Health Technologies Project.
Camp, SL, The Politics of U.S. Population Assistance, in: Mazur LA, ed., Beyond the Numbers: A Reader In Population Consumption and the Environment, California: Island Press, 1994.